Real Life Multicenter Comparison of 24-Month Outcomes of Anti-VEGF Therapy in Diabetic Macular Edema in Turkey: Ranibizumab vs. Aflibercept vs. Ranibizumab-Aflibercept Switch.
- Resource Type
- Article
- Source
- Medicina (1010660X); Feb2023, Vol. 59 Issue 2, p263, 11p
- Subject
MACULAR edema AFLIBERCEPT RANIBIZUMAB VASCULAR endothelial growth factor antagonists VISUAL acuity - Language
- ISSN
- 1010660X